Pharmaceuticals, rare diseases, and treatments by Catalyst Pharmaceuticals

  • Dan Blystone
  • 02.06.2026
Catalyst Pharmaceuticals stock edges higher while price consolidates near resistance levels
Catalyst Pharmaceuticals is shining a light on myasthenia gravis in a new awareness effort. The company is encouraging participation in the Myasthenia Gravis Association's 'light the globe' ...
  • Igor Krasulya
  • 12.03.2026
2025 results exceed expectations as 2026 outlook set, Catalyst Pharmaceuticals projects
Catalyst Pharmaceuticals President and CEO Rich Daly, accompanied by members of senior management, participated in the Barclays 28th Annual Global Healthcare Conference. The team presented ...
  • Elena Nikulina
  • 05.11.2025
Catalyst Pharmaceuticals recognized as top workplace for 2026
Catalyst Pharmaceuticals has been named a BioSpace 'Best Place to Work' for 2026. The recognition highlights the company's commitment to creating an enriching work environment. Factors ...